Qiagen and Roche Report Spike in MDx Revenues for FY 2010 | GenomeWeb

Qiagen and Roche this week each reported spikes in molecular diagnostics sales in 2010, although Roche reported flat sales for its applied science group.

For the fourth quarter of 2010, Qiagen's molecular diagnostics sales increased 7 percent on a constant exchange rate basis over 2009, primarily due to its infectious disease testing portfolio. Meantime, full-year 2010 molecular diagnostics sales rose 14 percent on a constant exchange rate basis over 2009. Qiagen said that molecular diagnostics comprises 48 percent of the company's total sales.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Sponsored by

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.